Abdominal manifestations of Henoch-Schönlein purpura in adults. A retrospective study of 23 cases

Gastrointestinal manifestations of Henoch-Schönlein purpura (HSP) in adults may be severe. Data about treatment are controversial and the outcome is seldom described. Twenty-three patients with gastrointestinal manifestations of HSP (ACR criteria) were retrospectively studied. We proposed to use cli...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:La revue de medecine interne 2009-08, Vol.30 (8), p.661-670
Hauptverfasser: Trouillier, S, André, M, Delèvaux, I, Mahamedi, H, Affo, C, Kintossou, R, Ruivard, M, Souteyrand, P, Philippe, P, Aumaître, O
Format: Artikel
Sprache:fre
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 670
container_issue 8
container_start_page 661
container_title La revue de medecine interne
container_volume 30
creator Trouillier, S
André, M
Delèvaux, I
Mahamedi, H
Affo, C
Kintossou, R
Ruivard, M
Souteyrand, P
Philippe, P
Aumaître, O
description Gastrointestinal manifestations of Henoch-Schönlein purpura (HSP) in adults may be severe. Data about treatment are controversial and the outcome is seldom described. Twenty-three patients with gastrointestinal manifestations of HSP (ACR criteria) were retrospectively studied. We proposed to use clinical and radiological (CT scan) severity scores to assess the usefulness and the efficacy of corticosteroid therapy. Age at onset ranged from 16 to 80 years (median 39). Gastrointestinal manifestations included abdominal pain (96%), vomiting (52%), gastrointestinal bleeding (39%), diarrhoea (13%) and intestinal obstruction (9%). Scores of disease clinical severity were calculated in 21 patients. Fourteen, three and four had severe, intermediate and mild disease, respectively. Ten patients in the group with severe clinical involvement underwent CT scan that showed severe radiological involvement (parietal thickening of several bowel loops of the same segment or several segments with ileal involvement). Eleven patients out of 14 with clinically severe disease were given corticosteroids. Two patients out of three with intermediate and three patients out of four with mild scores also received corticosteroids. The others received supportive care. In-patients with severe clinical scores, gastrointestinal symptoms improved within 2 days when they were given corticosteroids and within 12.3 days without corticosteroids (p
doi_str_mv 10.1016/j.revmed.2009.02.026
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_67500325</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67500325</sourcerecordid><originalsourceid>FETCH-LOGICAL-p139t-709598a00aef0e2703bca2f0c59066057df1cba33874e6397a599faa95d2bc93</originalsourceid><addsrcrecordid>eNo1kMFOwzAQRH0A0VL4A4R84pawsWsnPlYVtEiVONB7tHE2aqokDnFSqT_GD_BjGFGkkWYPb0baYewhgTiBRD8f44FOLZWxADAxiCB9xeYgllmUaS1n7Nb7IwAE2tywWWJkqgI7Z8WqKF1bd9jwFru6Ij_iWLvOc1fxLXXOHqIPe_j-6hqqO95PQxDycGI5NaOP-YoPNA7O92TH-kTcj1N5_k0LyS168nfsusLG0_3FF2z_-rJfb6Pd--ZtvdpFfSLNGKVglMkQAKkCEinIwqKowCoDWoNKyyqxBUqZpUvS0qSojKkQjSpFYY1csKe_2n5wn1P4I29rb6lpsCM3-VynCkAKFcDHCzgVYbO8H-oWh3P-P4r8AVSxZRc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67500325</pqid></control><display><type>article</type><title>Abdominal manifestations of Henoch-Schönlein purpura in adults. A retrospective study of 23 cases</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Trouillier, S ; André, M ; Delèvaux, I ; Mahamedi, H ; Affo, C ; Kintossou, R ; Ruivard, M ; Souteyrand, P ; Philippe, P ; Aumaître, O</creator><creatorcontrib>Trouillier, S ; André, M ; Delèvaux, I ; Mahamedi, H ; Affo, C ; Kintossou, R ; Ruivard, M ; Souteyrand, P ; Philippe, P ; Aumaître, O</creatorcontrib><description>Gastrointestinal manifestations of Henoch-Schönlein purpura (HSP) in adults may be severe. Data about treatment are controversial and the outcome is seldom described. Twenty-three patients with gastrointestinal manifestations of HSP (ACR criteria) were retrospectively studied. We proposed to use clinical and radiological (CT scan) severity scores to assess the usefulness and the efficacy of corticosteroid therapy. Age at onset ranged from 16 to 80 years (median 39). Gastrointestinal manifestations included abdominal pain (96%), vomiting (52%), gastrointestinal bleeding (39%), diarrhoea (13%) and intestinal obstruction (9%). Scores of disease clinical severity were calculated in 21 patients. Fourteen, three and four had severe, intermediate and mild disease, respectively. Ten patients in the group with severe clinical involvement underwent CT scan that showed severe radiological involvement (parietal thickening of several bowel loops of the same segment or several segments with ileal involvement). Eleven patients out of 14 with clinically severe disease were given corticosteroids. Two patients out of three with intermediate and three patients out of four with mild scores also received corticosteroids. The others received supportive care. In-patients with severe clinical scores, gastrointestinal symptoms improved within 2 days when they were given corticosteroids and within 12.3 days without corticosteroids (p&lt;0.0002). No side effect was observed with steroid therapy. These results suggest that corticosteroids may reduce abdominal symptoms of HSP in adults with clinically severe disease. They are safe when CT scan is performed.</description><identifier>ISSN: 0248-8663</identifier><identifier>DOI: 10.1016/j.revmed.2009.02.026</identifier><identifier>PMID: 19375200</identifier><language>fre</language><publisher>France</publisher><subject>Adolescent ; Adrenal Cortex Hormones - therapeutic use ; Adult ; Aged ; Aged, 80 and over ; Female ; Gastrointestinal Diseases - etiology ; Humans ; Male ; Middle Aged ; Purpura, Schoenlein-Henoch - complications ; Purpura, Schoenlein-Henoch - drug therapy ; Retrospective Studies ; Severity of Illness Index ; Young Adult</subject><ispartof>La revue de medecine interne, 2009-08, Vol.30 (8), p.661-670</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19375200$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Trouillier, S</creatorcontrib><creatorcontrib>André, M</creatorcontrib><creatorcontrib>Delèvaux, I</creatorcontrib><creatorcontrib>Mahamedi, H</creatorcontrib><creatorcontrib>Affo, C</creatorcontrib><creatorcontrib>Kintossou, R</creatorcontrib><creatorcontrib>Ruivard, M</creatorcontrib><creatorcontrib>Souteyrand, P</creatorcontrib><creatorcontrib>Philippe, P</creatorcontrib><creatorcontrib>Aumaître, O</creatorcontrib><title>Abdominal manifestations of Henoch-Schönlein purpura in adults. A retrospective study of 23 cases</title><title>La revue de medecine interne</title><addtitle>Rev Med Interne</addtitle><description>Gastrointestinal manifestations of Henoch-Schönlein purpura (HSP) in adults may be severe. Data about treatment are controversial and the outcome is seldom described. Twenty-three patients with gastrointestinal manifestations of HSP (ACR criteria) were retrospectively studied. We proposed to use clinical and radiological (CT scan) severity scores to assess the usefulness and the efficacy of corticosteroid therapy. Age at onset ranged from 16 to 80 years (median 39). Gastrointestinal manifestations included abdominal pain (96%), vomiting (52%), gastrointestinal bleeding (39%), diarrhoea (13%) and intestinal obstruction (9%). Scores of disease clinical severity were calculated in 21 patients. Fourteen, three and four had severe, intermediate and mild disease, respectively. Ten patients in the group with severe clinical involvement underwent CT scan that showed severe radiological involvement (parietal thickening of several bowel loops of the same segment or several segments with ileal involvement). Eleven patients out of 14 with clinically severe disease were given corticosteroids. Two patients out of three with intermediate and three patients out of four with mild scores also received corticosteroids. The others received supportive care. In-patients with severe clinical scores, gastrointestinal symptoms improved within 2 days when they were given corticosteroids and within 12.3 days without corticosteroids (p&lt;0.0002). No side effect was observed with steroid therapy. These results suggest that corticosteroids may reduce abdominal symptoms of HSP in adults with clinically severe disease. They are safe when CT scan is performed.</description><subject>Adolescent</subject><subject>Adrenal Cortex Hormones - therapeutic use</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Female</subject><subject>Gastrointestinal Diseases - etiology</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Purpura, Schoenlein-Henoch - complications</subject><subject>Purpura, Schoenlein-Henoch - drug therapy</subject><subject>Retrospective Studies</subject><subject>Severity of Illness Index</subject><subject>Young Adult</subject><issn>0248-8663</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kMFOwzAQRH0A0VL4A4R84pawsWsnPlYVtEiVONB7tHE2aqokDnFSqT_GD_BjGFGkkWYPb0baYewhgTiBRD8f44FOLZWxADAxiCB9xeYgllmUaS1n7Nb7IwAE2tywWWJkqgI7Z8WqKF1bd9jwFru6Ij_iWLvOc1fxLXXOHqIPe_j-6hqqO95PQxDycGI5NaOP-YoPNA7O92TH-kTcj1N5_k0LyS168nfsusLG0_3FF2z_-rJfb6Pd--ZtvdpFfSLNGKVglMkQAKkCEinIwqKowCoDWoNKyyqxBUqZpUvS0qSojKkQjSpFYY1csKe_2n5wn1P4I29rb6lpsCM3-VynCkAKFcDHCzgVYbO8H-oWh3P-P4r8AVSxZRc</recordid><startdate>200908</startdate><enddate>200908</enddate><creator>Trouillier, S</creator><creator>André, M</creator><creator>Delèvaux, I</creator><creator>Mahamedi, H</creator><creator>Affo, C</creator><creator>Kintossou, R</creator><creator>Ruivard, M</creator><creator>Souteyrand, P</creator><creator>Philippe, P</creator><creator>Aumaître, O</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200908</creationdate><title>Abdominal manifestations of Henoch-Schönlein purpura in adults. A retrospective study of 23 cases</title><author>Trouillier, S ; André, M ; Delèvaux, I ; Mahamedi, H ; Affo, C ; Kintossou, R ; Ruivard, M ; Souteyrand, P ; Philippe, P ; Aumaître, O</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p139t-709598a00aef0e2703bca2f0c59066057df1cba33874e6397a599faa95d2bc93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2009</creationdate><topic>Adolescent</topic><topic>Adrenal Cortex Hormones - therapeutic use</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Female</topic><topic>Gastrointestinal Diseases - etiology</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Purpura, Schoenlein-Henoch - complications</topic><topic>Purpura, Schoenlein-Henoch - drug therapy</topic><topic>Retrospective Studies</topic><topic>Severity of Illness Index</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Trouillier, S</creatorcontrib><creatorcontrib>André, M</creatorcontrib><creatorcontrib>Delèvaux, I</creatorcontrib><creatorcontrib>Mahamedi, H</creatorcontrib><creatorcontrib>Affo, C</creatorcontrib><creatorcontrib>Kintossou, R</creatorcontrib><creatorcontrib>Ruivard, M</creatorcontrib><creatorcontrib>Souteyrand, P</creatorcontrib><creatorcontrib>Philippe, P</creatorcontrib><creatorcontrib>Aumaître, O</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>La revue de medecine interne</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Trouillier, S</au><au>André, M</au><au>Delèvaux, I</au><au>Mahamedi, H</au><au>Affo, C</au><au>Kintossou, R</au><au>Ruivard, M</au><au>Souteyrand, P</au><au>Philippe, P</au><au>Aumaître, O</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Abdominal manifestations of Henoch-Schönlein purpura in adults. A retrospective study of 23 cases</atitle><jtitle>La revue de medecine interne</jtitle><addtitle>Rev Med Interne</addtitle><date>2009-08</date><risdate>2009</risdate><volume>30</volume><issue>8</issue><spage>661</spage><epage>670</epage><pages>661-670</pages><issn>0248-8663</issn><abstract>Gastrointestinal manifestations of Henoch-Schönlein purpura (HSP) in adults may be severe. Data about treatment are controversial and the outcome is seldom described. Twenty-three patients with gastrointestinal manifestations of HSP (ACR criteria) were retrospectively studied. We proposed to use clinical and radiological (CT scan) severity scores to assess the usefulness and the efficacy of corticosteroid therapy. Age at onset ranged from 16 to 80 years (median 39). Gastrointestinal manifestations included abdominal pain (96%), vomiting (52%), gastrointestinal bleeding (39%), diarrhoea (13%) and intestinal obstruction (9%). Scores of disease clinical severity were calculated in 21 patients. Fourteen, three and four had severe, intermediate and mild disease, respectively. Ten patients in the group with severe clinical involvement underwent CT scan that showed severe radiological involvement (parietal thickening of several bowel loops of the same segment or several segments with ileal involvement). Eleven patients out of 14 with clinically severe disease were given corticosteroids. Two patients out of three with intermediate and three patients out of four with mild scores also received corticosteroids. The others received supportive care. In-patients with severe clinical scores, gastrointestinal symptoms improved within 2 days when they were given corticosteroids and within 12.3 days without corticosteroids (p&lt;0.0002). No side effect was observed with steroid therapy. These results suggest that corticosteroids may reduce abdominal symptoms of HSP in adults with clinically severe disease. They are safe when CT scan is performed.</abstract><cop>France</cop><pmid>19375200</pmid><doi>10.1016/j.revmed.2009.02.026</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0248-8663
ispartof La revue de medecine interne, 2009-08, Vol.30 (8), p.661-670
issn 0248-8663
language fre
recordid cdi_proquest_miscellaneous_67500325
source Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE
subjects Adolescent
Adrenal Cortex Hormones - therapeutic use
Adult
Aged
Aged, 80 and over
Female
Gastrointestinal Diseases - etiology
Humans
Male
Middle Aged
Purpura, Schoenlein-Henoch - complications
Purpura, Schoenlein-Henoch - drug therapy
Retrospective Studies
Severity of Illness Index
Young Adult
title Abdominal manifestations of Henoch-Schönlein purpura in adults. A retrospective study of 23 cases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T16%3A47%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Abdominal%20manifestations%20of%20Henoch-Sch%C3%B6nlein%20purpura%20in%20adults.%20A%20retrospective%20study%20of%2023%20cases&rft.jtitle=La%20revue%20de%20medecine%20interne&rft.au=Trouillier,%20S&rft.date=2009-08&rft.volume=30&rft.issue=8&rft.spage=661&rft.epage=670&rft.pages=661-670&rft.issn=0248-8663&rft_id=info:doi/10.1016/j.revmed.2009.02.026&rft_dat=%3Cproquest_pubme%3E67500325%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67500325&rft_id=info:pmid/19375200&rfr_iscdi=true